EuroSCORE for Pulmonary Risk Stratification in CABG
For coronary artery bypass grafting (CABG), use the EuroSCORE risk stratification system, which includes chronic pulmonary disease as a weighted risk factor (score of 1 point for long-term use of bronchodilators or steroids for lung disease). 1
Why EuroSCORE is the Standard
The EuroSCORE is the validated, guideline-recommended tool for preoperative risk assessment in CABG patients 1. This scoring system specifically incorporates pulmonary status as one of 11 key risk factors and has been extensively validated for predicting in-hospital mortality and postoperative complications.
Key Pulmonary Parameters in EuroSCORE
The chronic pulmonary disease criterion is defined as:
- Long-term use of bronchodilators OR
- Long-term use of steroids for lung disease
- Weighted score: 1 point 1
Complete Risk Stratification Framework
Risk categories based on total EuroSCORE:
- Low risk: 0-2 points
- Medium risk: 3-5 points
- High risk: ≥6 points 1
Additional Pulmonary Considerations Beyond EuroSCORE
While EuroSCORE provides the foundational risk assessment, certain pulmonary parameters warrant specific attention:
Pulmonary Hypertension
- Systolic PAP >60 mmHg adds 2 points to the EuroSCORE 1
- This is a critical predictor: pulmonary hypertension was the only baseline variable predicting increased perioperative mortality in large CABG cohorts (odds ratio 2.1) 2
- Severe PH independently associates with in-hospital mortality (adjusted OR 6.9) and decreased 5-year survival (adjusted HR 2.4) 2
Specific Pulmonary Function Thresholds
Beyond the binary EuroSCORE classification, consider these specific parameters for enhanced risk stratification:
DLCO (Diffusing Capacity):
- DLCO <20% predicted indicates very high risk but may still be acceptable with careful patient selection 3
- DLCO >50% suggests small-airways disease rather than destructive pathology 3
Hypercapnia:
- pCO₂ >60 mmHg (8 kPa) was an exclusion criterion in major trials 3
- More stringent centers use pCO₂ >45 mmHg (6 kPa) as a cutoff 3
Common Pitfalls to Avoid
Don't rely solely on chronic pulmonary disease history - actively measure pulmonary artery pressures via echocardiography or right heart catheterization in patients with suspected pulmonary hypertension 2
Don't dismiss patients with elevated PAP automatically - the relationship between pulmonary hypertension and outcomes is complex, and multidisciplinary evaluation is essential 2
Don't forget that EuroSCORE slightly overestimates risk in contemporary practice due to therapeutic advances, but it remains the validated standard 1
Practical Application Algorithm
- Calculate baseline EuroSCORE including chronic pulmonary disease status (1 point if present)
- Add pulmonary hypertension assessment via echocardiography
- If systolic PAP >60 mmHg: add 2 points
- If systolic PAP 45-60 mmHg: consider right heart catheterization for precise measurement
- Stratify final risk: Low (0-2), Medium (3-5), or High (≥6)
- For high-risk patients: assemble multidisciplinary team including cardiac anesthesiologist and optimize pulmonary status preoperatively 2
The EuroSCORE remains the evidence-based standard for CABG risk stratification, with pulmonary parameters integrated as weighted components rather than requiring a separate pulmonary-specific tool.